Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preconceptional Sildenafil in Early Unexplained Recurrent Pregnancy Loss
NCT03766594Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP-001 in recurrent miscarriage (RPL) (2 arms), sponsored by Ain Shams University. Primary endpoint: Miscarriage rate. Started Jan 2018; status: completed.
02
Drugs
ASP-001
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT03766594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03766594.